|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN Estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Abdolmaleki F, Ghafouri-Fard S, Taheri M
and Omrani DM: P21-Associated ncRNA DNA damage-activated expression
in bladder cancer. Klin Onkol. 32:277–280. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jiang D, Zhang Y, Yang L, Lu W, Mai L, Guo
H and Liu X: Long noncoding RNA HCG22 suppresses proliferation and
metastasis of bladder cancer cells by regulation of PTBP1. J Cell
Physiol. 2:1711–1722. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hu J, Shan Y, Ma J, Pan Y, Zhou H, Jiang L
and Jia L: lncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal
cancer progression by regulating alpha-2,3 sialylation via PI3K/Akt
signaling. Int J Cancer. 145:450–460. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bai J, Xu J, Zhao J and Zhang R:
Downregulation of lncRNA AWPPH inhibits colon cancer cell
proliferation by downregulating GLUT-1. Oncol Lett. 18:2007–2012.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li Y, Zhao L, Zhao P and Liu Z: Long
non-coding RNA LINC00641 suppresses non-small-cell lung cancer by
sponging miR-424-5p to upregulate PLSCR4. Cancer Biomark. 26:79–91.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lee YR, Kim G, Tak WY, Jang SY, Kweon YO,
Park JG, Lee HW, Han YS, Chun JM, Park SY and Hur K: Circulating
exosomal noncoding RNAs as prognostic biomarkers in human
hepatocellular carcinoma. Int J Cancer. 144:1444–1452.
2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Li J, Wang W, Xia P, Wan L, Zhang L, Yu L,
Wang L, Chen X, Xiao Y and Xu C: Identification of a five-lncRNA
signature for predicting the risk of tumor recurrence in patients
with breast cancer. Int J Cancer. 143:2150–2160. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yao F, Wang Q and Wu Q: The prognostic
value and mechanisms of lncRNA UCA1 in human cancer. Cancer Manag
Res. 11:7685–7696. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang Y, Liao G, Bai J, Zhang X, Xu L,
Deng C, Yan M, Xie A, Luo T, Long Z, et al: Identifying cancer
driver lncRNAs bridged by functional effectors through integrating
multi-omics data in human cancers. Mol Ther Nucleic Acids.
17:362–373. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dai G, Huang C, Yang J, Jin L, Fu K, Yuan
F, Zhu J and Xue B: lncRNA SNHG3 promotes bladder cancer
proliferation and metastasis through miR-515-5p/GINS2 axis. J Cell
Mol Med. 24:9231–9243. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li Y, Shi B, Dong F, Zhu X, Liu B and Liu
Y: lncRNA KCNQ1OT1 facilitates the progression of bladder cancer by
targeting miR-218-5p/HS3ST3B1. Cancer Gene Ther. 28:212–220.
2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li JR, Sun CH, Li W, Chao RF, Huang CC,
Zhou XJ and Liu CC: Cancer RNA-Seq Nexus: A database of
phenotype-specific transcriptome profiling in cancer cells. Nucleic
Acids Res. 44:D944–D951. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Paraskevopoulou MD, Georgakilas G,
Kostoulas N, Reczko M, Maragkakis M, Dalamagas TM and Hatzigeorgiou
AG: DIANA-lncBase: Experimentally verified and computationally
predicted microRNA targets on long non-coding RNAs. Nucleic Acids
Res. 41:D239–D245. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Huang HY, Li J, Tang Y, Huang YX, Chen YG,
Xie YY, Zhou ZY, Chen XY, Ding SY, Luo MF, et al: MethHC 2.0:
Information repository of DNA methylation and gene expression in
human cancer. Nucleic Acids Res. 49:D1268–D1275. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yuan S, Luan X, Han G, Guo K, Wang S and
Zhang X: LINC01638 lncRNA mediates the postoperative distant
recurrence of bladder cancer by upregulating ROCK2. Oncol Lett.
18:5392–5398. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hu X, Feng H, Huang H, Gu W, Fang Q, Xie
Y, Qin C and Hu X: Downregulated long noncoding RNA PART1 inhibits
proliferation and promotes apoptosis in bladder cancer. Technol
Cancer Res Treat. 18(1533033819846638)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lyu L, Xiang W, Zhu JY, Huang T, Yuan JD
and Zhang CH: Integrative analysis of the lncRNA-associated ceRNA
network reveals lncRNAs as potential prognostic biomarkers in human
muscle-invasive bladder cancer. Cancer Manag Res. 11:6061–6077.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Dai L, Chai CM, Shen TY, Tian Y, Shang ZQ
and Niu YJ: lncRNA ITGB1 promotes the development of bladder cancer
through regulating microRNA-10a expression. Eur Rev Med Pharmacol
Sci. 23:6858–6867. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fang C, Xu L, He W, Dai J and Sun F: Long
noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in
bladder cancer via modulating the miR-223-HSP90B1 axis. Cell Cycle.
18:3288–3299. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yang Y, Zhang F, Huang H, Xie Z, Huang W,
Xie H and Wang F: Long noncoding RNA LINC00319 regulates ROMO1
expression and promotes bladder cancer progression via
miR-4492/ROMO1 axis. J Cell Physiol. 4:3768–3775. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhuang C, Ma Q, Zhuang C, Ye J, Zhang F
and Gui Y: lncRNA GClnc1 promotes proliferation and invasion of
bladder cancer through activation of MYC. FASEB J. 33:11045–11059.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Peng H and Li H: The encouraging role of
long noncoding RNA small nuclear RNA host gene 16 in
epithelial-mesenchymal transition of bladder cancer via directly
acting on miR-17-5p/metalloproteinases 3 axis. Mol Carcinog.
58:1465–1480. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Peng Y, Leng W, Duan S and Hong M: Long
noncoding RNA BLACAT1 is overexpressed in hepatocellular carcinoma
and its downregulation suppressed cancer cell development through
endogenously competing against hsa-miR-485-5p. Biomed Pharmacother.
116(109027)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang J, Lu Y, Ding H, Gu T, Gong C, Sun J,
Zhang Z, Zhao Y and Ma C: The miR-875-5p inhibits SATB2 to promote
the invasion of lung cancer cells. Gene. 644:13–19. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Davidsson J and Johansson B: Methylation
and expression analyses of Pallister-Killian syndrome reveal
partial dosage compensation of tetrasomy 12p and hypomethylation of
gene-poor regions on 12p. Epigenetics. 11:194–204. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yoshida A, Yoneda-Kato N, Panattoni M,
Pardi R and Kato JY: CSN5/Jab1 controls multiple events in the
mammalian cell cycle. FEBS Lett. 584:4545–4552. 2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zheng J, Zhang H, Ma R, Liu H and Gao P:
Long non-coding RNA KRT19P3 suppresses proliferation and metastasis
through COPS7A-mediated NF-κB pathway in gastric cancer. Oncogene.
45:7073–7088. 2019.PubMed/NCBI View Article : Google Scholar
|
